Petragen, Inc.

New Filing
CIK: 0001844157·Biotechnology·DELAWARE·Filed: Jun 23, 2026
Total Offering

$1,000,000

Amount Sold

$495,000

Investors

9

First Sale

Apr 5, 2026

Offering Details

Type
Equity, Other: Common Shares
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
David Kolb
Demetrios Braddock, MD, PhD

Company

Petragen, Inc.

12555 Orange Drive, Suite 236

Davie, FL, 33330

6173026670

SEC Filing

0001844157-26-000005

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free